25 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ASMB Assembly Biosciences, Inc. $34.41 $875.61M Downtrend
Article Searches
Assembly Biosciences (ASMB) Presents At Jefferies 2017 Global Healthcare Conference - Slideshow https://seekingalpha.com/article/4079974-assembly-biosciences-asmb-presents-jefferies-2017-global-healthcare-conference-slideshow?source=feed_sector_healthcare Jun 08, 2017 - The following slide deck was published by Assembly Biosciences, Inc. in conjunction with this event.
Assembly Biosciences (ASMB) Presents At Cambridge Healthtech Institute's 15th Annual Discovery On Target - Slideshow https://seekingalpha.com/article/4109521-assembly-biosciences-asmb-presents-cambridge-healthtech-institutes-15th-annual-discovery?source=feed_sector_healthcare Sep 26, 2017 - The following slide deck was published by Assembly Biosciences, Inc. in conjunction with this event.
Your Daily Pharma Scoop: AstraZeneca's Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy? https://seekingalpha.com/article/4114305-daily-pharma-scoop-astrazenecas-imfinzi-sbla-ablynx-u-s-ipo-teva-buy?source=feed_sector_healthcare Oct 18, 2017 - Is Teva a buy at its 52-week lows?AstraZeneca’s Imfinzi submits a new sBLA for stage 3 NSCLC.Ablynx files an IPO for $175M.
Healthcare: The 'Week That Was' Was Good https://seekingalpha.com/article/4138062-healthcare-week-was-good?source=feed_all_articles Jan 17, 2018 - Last month, I  explained my rationale for expecting favorable performance from healthcare stocks in January. In biopharmaceuticals, I highlighted Juno Therapeutics, bluebird bio, Madrigal, Arbutus, Co
Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology ... http://www.gurufocus.com/news/649868/orbimed-advisors-llc-buys-regeneron-pharmaceuticals-inc-amicus-therapeutics-inc-loxo-oncology-inc-sells-incyte-corp-aetna-inc-biogen-inc Mar 06, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Mar 06, 2018
Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology ... http://www.gurufocus.com/news/651902/orbimed-advisors-llc-buys-regeneron-pharmaceuticals-inc-amicus-therapeutics-inc-loxo-oncology-inc-sells-incyte-corp-aetna-inc-biogen-inc Mar 12, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Mar 12, 2018
Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology ... http://www.gurufocus.com/news/652597/orbimed-advisors-llc-buys-regeneron-pharmaceuticals-inc-amicus-therapeutics-inc-loxo-oncology-inc-sells-incyte-corp-aetna-inc-biogen-inc Mar 14, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Mar 14, 2018
Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology ... http://www.gurufocus.com/news/658490/orbimed-advisors-llc-buys-regeneron-pharmaceuticals-inc-amicus-therapeutics-inc-loxo-oncology-inc-sells-incyte-corp-aetna-inc-biogen-inc Mar 29, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Mar 29, 2018
ASMB: Chardan Capital Markets cuts to Neutral http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180413073148 Apr 13, 2018 - Chardan Capital Markets issues rating change for ASMB
Assembly Biosciences misses by $0.04, beats on revenue https://seekingalpha.com/news/3353430-assembly-biosciences-misses-0_04-beats-revenue?source=feed_news_all May 07, 2018 - Assembly Biosciences (NASDAQ:ASMB): Q1 EPS of -$0.80 misses by $0.04.Revenue of $3.57M (+425.0% Y/Y) beats by $1.69M.Press Release

Pages: 123

Page 1>

Related Companies

Name Exchange Price Mkt Cap
RCKT Rocket Pharmaceuticals, Inc. NASDAQ $22.24 $882.06M
RVNC Revance Therapeutics, Inc. NASDAQ $23.5001 $868.04M
AMPH Amphastar Pharmaceuticals, Inc. NASDAQ $18.33 $847.88M
AMRN Amarin Corporation plc NASDAQ $2.83 $838.67M
CTMX CytomX Therapeutics, Inc. NASDAQ $18.52 $832.73M
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Assembly Biosciences
ASMB - Google Finance https://www.google.com/finance?q=ASMB Industry related info and international coverage Summary News
ASMB - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=ASMB Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options